Investment
Rubicon reiterates IPO plans for ArborGen, laments languishing share price
Rubicon, the forestry biotech company spun out of Fletcher Challenge, reiterated plans for an initial public offer for ArborGen, the biotech forest.
By Pattrick Smellie
•
3 min read
•
Fri, 5th Dec 2014